caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1144339383

Matthew PalickaARNP

Nurse PractitionerNaples, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 340075
Hospital
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$37
Payment records
7
By payment type
Food and Beverage$37
Top paying entities
Food and Beverage$37
PRESCRIBING · PART D · 2024
Total Rx claims
36
Beneficiaries
—
Total drug cost
$238
Distinct drugs
3
Brand share
0.0%
Top prescribed drugs
Cefdinir13 claims
Metoprolol Succinate12 claims
Doxycycline Hyclate11 claims
REFERRAL NETWORK

Where Matthew Palicka's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
William Ford
Diagnostic Radiology · Naples, FL
1115
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
NAPLES COMMUNITY HOSPITAL INC1421
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
187
Unique beneficiaries
—
Total services
323
Distinct HCPCS
4
Medicare payment
$21K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 14,952 Nurse Practitioner providers in FL — above median (cohort median 263).